Funding Details
- Date Award
- May 13, 2024
- Vertical
- Computational Bio
- Funding URL
- View Funding Page
Company Info
- Organizations Involved
- IndieBio NY 04
- Company Description
- Neurological disorders, like Alzheimer’s, can be challenging to diagnose, especially earlier in the disease progression when symptoms are subtle. Based on the groundbreaking research carried out in Scott Small’s lab at Columbia University, Tesarakt uses AI and machine learning to enhance the predictive power of neurodiagnosis using conventional MRI scans, and powered with access to the largest database of MRI scans. Parkinson’s disease & Alzheimer’s disease are the initial indications they are pursuing, with the potential to detect both diseases years before first symptoms arise.
- Market
- Human Health
- Location
-
United States
Links